Table 3.
Group | CON (mean±SE) | GPA (mean±SE) | PRE (mean±SE) | PRO (mean±SE) | SYM (mean±SE) |
---|---|---|---|---|---|
GIT (g) | 166.8±6.1ab | 165.8±4.3a | 190.3±6.8b | 184.7±5.7ab | 175.1±6.6ab |
GIT (cm) | 207±2.4ab | 186.8±5.6a | 216.2±6.3b | 202.8±1.9ab | 206.4±8ab |
Liver (g) | 53.4±2.7ab | 47.8±3.4a | 62.7±1.7b | 61.8±4.5b | 51.7±2.4ab |
Gallbladder (g) | 2.3±0.2a | 2.3±0.1a | 2.6±0.2a | 2.1±0.2a | 2.8±0.2a |
Spleen (g) | 2.8±0.3a | 2.8±0.1a | 3.5±0.4a | 2.8±0.2a | 3.0±0.3a |
CON, control; GPA, with growth-promoting antibiotic; PRE, with agave fructan capsules; PRO, with Bifidobacterium animalis capsules; SYM, with symbiotic capsules; SE, standard error; GIT, gastrointestinal tract; cm, centimeter; g, grams.
Different letters indicate significant differences between groups (p<0.05).